Healthtech B-Corp Radicle Science has appointed Pamela Jones Harbour, the first African-American female Commissioner of the U.S. Federal Trade Commission (FTC), to its Strategic Advisory Board. Radicle said Harbour’s addition underscores its commitment to innovative research and regulatory compliance for the dietary supplement industry.

“I am honored to join Radicle Science at a time when regulatory and market forces have rendered proof of effectiveness a ‘must have’ for dietary supplements and other wellness products,” said Harbour. “Not only does Radicle’s transformative Proof-as-a-Service approach provide gold-standard clinical evidence that aligns with expectations from the FDA, FTC, consumers, and healthcare providers, but the large scale and the diversity of their study populations pave the path towards personalized treatments for the population at large. That’s the kind of health equity I am thrilled to be a part of creating.”

Radicle Science has been conducting some of history’s largest rigorous clinical trials on dietary supplements, with publications in peer-reviewed journals such as the Journal of the American Nutrition Association and Nutrients.

Since launching in 2021, the B-corp has studied 50,000+ diverse Americans, 3 times more than all participants in NIH-funded phase 3 trials during the same time.

Dr. Jeff Chen, co-founder and CEO of Radicle Science, expressed his excitement about Harbour joining the advisory board, stating, “Pamela Harbour’s extensive regulatory expertise is a perfectly timed addition to our advisory board. We look forward to collaborating with Pamela to power the dietary supplement industry with objective, gold-standard clinical evidence of effectiveness to drive consumer trust across the wellness industry.”

Harbour joins the ranks of industry luminaries on Radicle Science’s advisory board, including Peter Diamandis (XPRIZE founder), Dr. Jonathan Fielding (UCLA’s Fielding School of Public Health), Tom Aarts (Nutrition Business Journal’s Cofounder), Joe Dickson (Whole Foods’ former Global Director of Quality Standards), and Rhona Applebaum (Coca Cola’s first Chief Science and Health Officer).